Eating Disorders: The Way Forward - A Strategic Communication Framework is a necessary compendium document to the Eating Disorders: The Way Forward, An Australian National Framework.
Read more
Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more
Eating Disorders: A Professional Resource for General Practitioners has been updated to align with NEDC’s new resource, Eating Disorder Core Skills: eLearning for GPs.
Read more
